138 related articles for article (PubMed ID: 36197797)
1. Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression.
Lu X; Xin DE; Du JK; Zou QC; Wu Q; Zhang YS; Deng W; Yue J; Fan XS; Zeng Y; Cheng X; Li X; Hou Z; Mohan M; Zhao TC; Lu X; Chang Z; Xu L; Sun Y; Zu X; Zhang Y; Chinn YE
Cancer Res; 2022 Dec; 82(23):4400-4413. PubMed ID: 36197797
[TBL] [Abstract][Full Text] [Related]
2. Lysyl Oxidase 3 Is a Dual-Specificity Enzyme Involved in STAT3 Deacetylation and Deacetylimination Modulation.
Ma L; Huang C; Wang XJ; Xin DE; Wang LS; Zou QC; Zhang YS; Tan MD; Wang YM; Zhao TC; Chatterjee D; Altura RA; Wang C; Xu YS; Yang JH; Fan YS; Han BH; Si J; Zhang X; Cheng J; Chang Z; Chin YE
Mol Cell; 2017 Jan; 65(2):296-309. PubMed ID: 28065600
[TBL] [Abstract][Full Text] [Related]
3. Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1.
Kim BR; Dong SM; Seo SH; Lee JH; Lee JM; Lee SH; Rho SB
Cell Signal; 2014 Sep; 26(9):1765-73. PubMed ID: 24863880
[TBL] [Abstract][Full Text] [Related]
4. CEBPA facilitates LOXL2 and LOXL3 transcription to promote BCL-2 stability and thus enhances the growth and metastasis of lung carcinoma cells in vitro.
Fan L; Jiang W; Chen C; Gao H; Shi J; Wang D
Exp Cell Res; 2024 Feb; 435(2):113937. PubMed ID: 38242344
[TBL] [Abstract][Full Text] [Related]
5. Lysine Deacetylation Is a Key Function of the Lysyl Oxidase Family of Proteins in Cancer.
Wu X; Li X; Wang L; Bi X; Zhong W; Yue J; Chin YE
Cancer Res; 2024 Mar; 84(5):652-658. PubMed ID: 38194336
[TBL] [Abstract][Full Text] [Related]
6. Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation.
Iftikhar M; Hurtado P; Bais MV; Wigner N; Stephens DN; Gerstenfeld LC; Trackman PC
J Biol Chem; 2011 Jan; 286(2):909-18. PubMed ID: 21071451
[TBL] [Abstract][Full Text] [Related]
7. LOXL2 in cancer: regulation, downstream effectors and novel roles.
Wen B; Xu LY; Li EM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188435. PubMed ID: 32976981
[TBL] [Abstract][Full Text] [Related]
8.
Yang YL; Tsai MC; Chang YH; Wang CC; Chu PY; Lin HY; Huang YH
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206143
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.
Okada K; Moon HJ; Finney J; Meier A; Mure M
Biochemistry; 2018 Dec; 57(51):6973-6983. PubMed ID: 30499665
[TBL] [Abstract][Full Text] [Related]
10. LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity.
Almacellas-Rabaiget O; Monaco P; Huertas-Martinez J; García-Monclús S; Chicón-Bosch M; Maqueda-Marcos S; Fabra-Heredia I; Herrero-Martín D; Rello-Varona S; de Alava E; López-Alemany R; Giangrande PH; Tirado OM
Cancer Lett; 2020 Apr; 474():1-14. PubMed ID: 31911079
[TBL] [Abstract][Full Text] [Related]
11. Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification.
Morris SA; Rao B; Garcia BA; Hake SB; Diaz RL; Shabanowitz J; Hunt DF; Allis CD; Lieb JD; Strahl BD
J Biol Chem; 2007 Mar; 282(10):7632-40. PubMed ID: 17189264
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin.
Schmelzer CEH; Heinz A; Troilo H; Lockhart-Cairns MP; Jowitt TA; Marchand MF; Bidault L; Bignon M; Hedtke T; Barret A; McConnell JC; Sherratt MJ; Germain S; Hulmes DJS; Baldock C; Muller L
FASEB J; 2019 Apr; 33(4):5468-5481. PubMed ID: 30676771
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of the promoter of cancer-related gene LOXL2.
Liu X; Liu T; Hu L; Jiang T; Liu H; Wang Y; Lei Y; Zhu J; Bu Y
Exp Cell Res; 2020 Feb; 387(2):111786. PubMed ID: 31870772
[TBL] [Abstract][Full Text] [Related]
14. The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation.
Lugassy J; Zaffryar-Eilot S; Soueid S; Mordoviz A; Smith V; Kessler O; Neufeld G
J Biol Chem; 2012 Jan; 287(5):3541-9. PubMed ID: 22157764
[TBL] [Abstract][Full Text] [Related]
15. The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin.
Kim YM; Kim EC; Kim Y
Mol Biol Rep; 2011 Jan; 38(1):145-9. PubMed ID: 20306300
[TBL] [Abstract][Full Text] [Related]
16. Scavenger Receptor Cysteine-Rich domains of Lysyl Oxidase-Like2 regulate endothelial ECM and angiogenesis through non-catalytic scaffolding mechanisms.
Umana-Diaz C; Pichol-Thievend C; Marchand MF; Atlas Y; Salza R; Malbouyres M; Barret A; Teillon J; Ardidie-Robouant C; Ruggiero F; Monnot C; Girard P; Guilluy C; Ricard-Blum S; Germain S; Muller L
Matrix Biol; 2020 Jun; 88():33-52. PubMed ID: 31759052
[TBL] [Abstract][Full Text] [Related]
17. LOXL2 upregulates hypoxia‑inducible factor‑1α signaling through Snail‑FBP1 axis in hepatocellular carcinoma cells.
Fan Z; Zheng W; Li H; Wu W; Liu X; Sun Z; Hu H; Du L; Jia Q; Liu Q
Oncol Rep; 2020 May; 43(5):1641-1649. PubMed ID: 32323822
[TBL] [Abstract][Full Text] [Related]
18. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
[TBL] [Abstract][Full Text] [Related]
19. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
Peinado H; Moreno-Bueno G; Hardisson D; Pérez-Gómez E; Santos V; Mendiola M; de Diego JI; Nistal M; Quintanilla M; Portillo F; Cano A
Cancer Res; 2008 Jun; 68(12):4541-50. PubMed ID: 18559498
[TBL] [Abstract][Full Text] [Related]
20. The function and mechanisms of action of LOXL2 in cancer (Review).
Wu L; Zhu Y
Int J Mol Med; 2015 Nov; 36(5):1200-4. PubMed ID: 26329904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
